Hasegawa S - Search Results

1

Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.

Hasegawa S, Tanaka T, Nangaku M. Hasegawa S, et al. Curr Opin Nephrol Hypertens. 2018 Sep;27(5):331-338. doi: 10.1097/MNH.0000000000000431. Curr Opin Nephrol Hypertens. 2018. PMID: 30067604 Review.

2

Positron emission tomography in the diagnosis of cyst infections.

Hasegawa S, Kato H, Hamasaki Y, Koiwa T, Nangaku M. Hasegawa S, et al. Kidney Int. 2017 Mar;91(3):759. doi: 10.1016/j.kint.2016.10.025. Kidney Int. 2017. PMID: 28202176 Free article. No abstract available.

3

Dietary Metabolites and Chronic Kidney Disease.

Hasegawa S, Jao TM, Inagi R. Hasegawa S, et al. Nutrients. 2017 Apr 4;9(4):358. doi: 10.3390/nu9040358. Nutrients. 2017. PMID: 28375181 Free PMC article. Review.

4

Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.

Saito H, Tanaka T, Tanaka S, Higashijima Y, Yamaguchi J, Sugahara M, Ito M, Uchida L, Hasegawa S, Wakashima T, Fukui K, Nangaku M. Saito H, et al. Among authors: hasegawa s. Physiol Rep. 2018 May;6(10):e13707. doi: 10.14814/phy2.13707. Physiol Rep. 2018. PMID: 29845768 Free PMC article.

5

Recent advances in renal regeneration.

Hasegawa S, Tanaka T, Nangaku M. Hasegawa S, et al. F1000Res. 2019 Feb 25;8:F1000 Faculty Rev-216. doi: 10.12688/f1000research.17127.1. eCollection 2019. F1000Res. 2019. PMID: 30828435 Free PMC article. Review.

6

Comprehensive three-dimensional analysis (CUBIC-kidney) visualizes abnormal renal sympathetic nerves after ischemia/reperfusion injury.

Hasegawa S, Susaki EA, Tanaka T, Komaba H, Wada T, Fukagawa M, Ueda HR, Nangaku M. Hasegawa S, et al. Kidney Int. 2019 Jul;96(1):129-138. doi: 10.1016/j.kint.2019.02.011. Epub 2019 Apr 9. Kidney Int. 2019. PMID: 30979565 Free article.

7

The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease.

Hasegawa S, Tanaka T, Saito T, Fukui K, Wakashima T, Susaki EA, Ueda HR, Nangaku M. Hasegawa S, et al. Kidney Int. 2020 May;97(5):934-950. doi: 10.1016/j.kint.2019.12.007. Epub 2019 Dec 25. Kidney Int. 2020. PMID: 32171449 Free article.

8

Vagus nerve stimulation even after injury ameliorates cisplatin-induced nephropathy via reducing macrophage infiltration.

Uni R, Inoue T, Nakamura Y, Fukaya D, Hasegawa S, Wu CH, Fujii R, Surattichaiyakul B, Peerapanyasut W, Ozeki A, Akimitsu N, Wada Y, Nangaku M, Inagi R. Uni R, et al. Among authors: hasegawa s. Sci Rep. 2020 Jun 11;10(1):9472. doi: 10.1038/s41598-020-66295-0. Sci Rep. 2020. PMID: 32528023 Free PMC article.

9

Activation of Sympathetic Signaling in Macrophages Blocks Systemic Inflammation and Protects against Renal Ischemia-Reperfusion Injury.

Hasegawa S, Inoue T, Nakamura Y, Fukaya D, Uni R, Wu CH, Fujii R, Peerapanyasut W, Taguchi A, Kohro T, Yamada S, Katagiri M, Ko T, Nomura S, Nakanishi Ozeki A, Susaki EA, Ueda HR, Akimitsu N, Wada Y, Komuro I, Nangaku M, Inagi R. Hasegawa S, et al. J Am Soc Nephrol. 2021 Jul;32(7):1599-1615. doi: 10.1681/ASN.2020121723. Epub 2021 Apr 19. J Am Soc Nephrol. 2021. PMID: 33875568 Free PMC article.

10

Decreased IFT88 expression with primary cilia shortening causes mitochondrial dysfunction in cisplatin-induced tubular injury.

Fujii R, Hasegawa S, Maekawa H, Inoue T, Yoshioka K, Uni R, Ikeda Y, Nangaku M, Inagi R. Fujii R, et al. Among authors: hasegawa s. Am J Physiol Renal Physiol. 2021 Sep 1;321(3):F278-F292. doi: 10.1152/ajprenal.00673.2020. Epub 2021 Aug 2. Am J Physiol Renal Physiol. 2021. PMID: 34338030 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,016 results

Search Page